세계의 트리코모나스 신속 검사 시장 : 검사 유형별, 샘플 유형별, 최종 사용자별, 국가별, 지역별 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

Trichomonas Rapid Testing Market size was valued at US$ 469 Million in 2024, expanding at a CAGR of 5.2% from 2025 to 2032.

The Trichomonas Rapid Testing Market revolves around the development, manufacturing, and End-user of diagnostic tools designed to quickly detect Trichomonas vaginalis infections, a common sexually transmitted infection. These rapid tests offer faster results compared to traditional laboratory-based methods, enabling timely diagnosis and treatment. Growing awareness of sexually transmitted infections and increased emphasis on reproductive health have fueled demand. Technological advancements in molecular diagnostics and point-of-care testing devices have further expanded market opportunities. The availability of easy-to-use, cost-effective rapid tests in clinical settings enhances patient management, especially in resource-limited environments.

Moreover, the rise in sexually active populations and improved healthcare infrastructure globally are contributing factors. Regulatory support for faster diagnostic approvals is accelerating market growth. The market also benefits from increased screening campaigns and initiatives aimed at reducing STI transmission. Overall, the market is progressing towards more sensitive, user-friendly, and portable testing solutions. Challenges include the need for high specificity and sensitivity to avoid false results and competition from alternative diagnostic methods.

Trichomonas Rapid Testing Market- Market Dynamics

Rising prevalence of sexually transmitted infections drives demand for rapid diagnostics.

The increasing incidence of sexually transmitted infections worldwide has created an urgent need for quick and reliable diagnostic tools. Traditional testing methods often require extended processing times and specialized laboratory infrastructure, which can delay diagnosis and treatment. Rapid testing for Trichomonas infections allows healthcare providers to identify and manage cases more efficiently, reducing transmission rates.

Early detection is particularly critical in controlling outbreaks and improving patient outcomes. Additionally, the rise in awareness about sexual health and government-supported screening programs promotes wider adoption of these rapid tests. This demand is amplified in low-resource settings where laboratory facilities are scarce, making point-of-care rapid tests an essential healthcare tool. The driver aligns closely with public health goals to curb STI spread and improve reproductive health globally.

Trichomonas Rapid Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.2% over the forecast period (2025-2032)

Based on Test Type segmentation, Molecular Rapid Tests were predicted to show maximum market share in the year 2024

Based on Sample Type segmentation, Vaginal/Urethral Swabs was the leading Sample Type in 2024

Based on End-user segmentation, Hospitals was the leading Sample Type in 2024

On the basis of region, North America was the leading revenue generator in 2024

Trichomonas Rapid Testing Market- Segmentation Analysis:

The Global Trichomonas Rapid Testing Market is segmented on the basis of Test Type, Sample Type, End-user, and Region.

The market is divided into three categories based on Test Type: Molecular Rapid Tests, Immunochromatographic Tests, and Enzyme Immunoassays. Among Test Types, Molecular Rapid Tests dominate the market due to their superior accuracy and sensitivity in detecting Trichomonas vaginalis. Molecular methods, such as nucleic acid amplification tests (NAATs), provide reliable detection even in cases of low pathogen load, which immunoassays or chromatographic tests may miss.

These tests offer rapid turnaround times and can be used at or near the point of care, making them attractive for clinical settings. Despite generally higher costs, the clinical benefits and improved patient outcomes justify their preference among healthcare providers. Continuous advancements have made molecular rapid tests more user-friendly and accessible, thus increasing adoption rates. Additionally, these tests are often integrated into multiplex platforms that detect multiple STIs simultaneously, further enhancing their market appeal.

The market is divided into two categories based on Sample Type: Vaginal/Urethral Swabs, Urine Samples. In the Trichomonas rapid testing market, vaginal and urethral swabs are the most dominant sample type. These swabs are preferred in clinical settings due to their high diagnostic accuracy, particularly when used with rapid antigen and nucleic acid amplification tests (NAATs).

They are widely adopted in hospitals, diagnostic labs, and sexual health clinics, offering reliable results within minutes. The consistency and regulatory acceptance of swab-based testing make it the gold standard, especially for symptomatic female patients. While urine samples are gaining traction for being non-invasive and suitable for at-home testing, swabs continue to lead due to their superior sensitivity and widespread usage.

Trichomonas Rapid Testing Market- Geographical Insights

The North American market, particularly the United States and Canada, is a significant contributor to the global Trichomonas rapid testing market. Advanced healthcare infrastructure, widespread availability of rapid diagnostic tools, and proactive government screening programs boost regional growth. The presence of key market players with strong R&D capabilities and End-user networks supports product innovation and accessibility.

Public health initiatives targeting STI prevention and early diagnosis are well-established, creating steady demand for rapid testing kits. The region also benefits from a high level of patient awareness and insurance coverage policies that support diagnostic testing. Regulatory frameworks in North America encourage rapid approvals of novel testing technologies, further driving market expansion.

The U.S. dominates the North American Trichomonas rapid testing market due to its sophisticated healthcare system and increasing emphasis on sexual health screening. The country has robust funding for STI prevention and control programs, fostering demand for efficient diagnostic solutions. Major healthcare providers and clinics increasingly adopt rapid testing to improve patient throughput and clinical outcomes. Technological innovation, including nucleic acid amplification-based rapid tests, is prevalent, offering enhanced sensitivity and ease of use.

The growing focus on reducing healthcare costs and hospital visits also encourages point-of-care testing adoption. Market players benefit from streamlined regulatory pathways by the FDA, facilitating quicker market entry for new products. However, challenges such as competition from alternative testing methods and the need for continuous product validation remain. Collaborations between diagnostic companies and healthcare organizations further strengthen the market's growth potential in the U.S.

Trichomonas Rapid Testing Market- Competitive Landscape:

The Trichomonas rapid testing market is highly competitive, with key players focusing on product innovation, partnerships, and strategic acquisitions to strengthen their market positions. Companies are investing in research and development to improve test sensitivity, reduce turnaround times, and enhance ease of use. The trend towards multiplex testing platforms that detect multiple sexually transmitted infections simultaneously is gaining traction. Market participants actively expand their geographic footprints by collaborating with healthcare providers and government bodies to promote screening initiatives.

Pricing strategies and reimbursement policies significantly impact market competition, encouraging players to balance cost-effectiveness with technological advancement. Regulatory compliance and timely product approvals are crucial competitive factors. Smaller players often focus on niche segments or regional markets, while larger companies leverage extensive End-user networks and brand recognition. Overall, the market is marked by continuous innovation and evolving customer needs, driving competitive dynamics.

Recent Developments:

In May 2025, Quidel Corporation announced the launch of an improved molecular rapid test for Trichomonas with enhanced sensitivity and faster results.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TRICHOMONAS RAPID TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Quidel Corporation
• Hologic, Inc.
• Sekisui Diagnostics
• Abbott Laboratories
• Becton Dickinson and Company
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• Meridian Bioscience, Inc.
• Siemens Healthineers
• Roche Diagnostics
• Alere Inc. (now part of Abbott)
• Cepheid
• F. Hoffmann-La Roche Ltd
• Luminex Corporation
• BioMerieux SA
• Ortho Clinical Diagnostics
• Mobidiag Oy
• GenProbe, Inc.
• Diasorin S.p.A
• Nanosphere, Inc.

GLOBAL TRICHOMONAS RAPID TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

• Molecular Rapid Tests
• Immunochromatographic Tests
• Enzyme Immunoassays

GLOBAL TRICHOMONAS RAPID TESTING MARKET, BY SAMPLE TYPE- MARKET ANALYSIS, 2019 - 2032

• Vaginal/Urethral Swabs
• Urine Samples

GLOBAL TRICHOMONAS RAPID TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

• Hospitals
• Diagnostic Laboratories
• Clinics and Physician Offices
• Point-of-Care Testing Centers

GLOBAL TRICHOMONAS RAPID TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Trichomonas Rapid Testing Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Trichomonas Rapid Testing Market Snippet by Test Type
  • 2.1.2. Trichomonas Rapid Testing Market Snippet by Sample Type
  • 2.1.3. Trichomonas Rapid Testing Market Snippet by End-user
  • 2.1.4. Trichomonas Rapid Testing Market Snippet by Country
  • 2.1.5. Trichomonas Rapid Testing Market Snippet by Region
• 2.2. Competitive Insights

3. Trichomonas Rapid Testing Key Market Trends

• 3.1. Trichomonas Rapid Testing Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Trichomonas Rapid Testing Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Trichomonas Rapid Testing Market Opportunities
• 3.4. Trichomonas Rapid Testing Market Future Trends

4. Trichomonas Rapid Testing Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Trichomonas Rapid Testing Market: Impact of Escalating Geopolitical Tensions

• 5.1. Impact of COVID-19 Pandemic
• 5.2. Impact of Russia-Ukraine War
• 5.3. Impact of Middle East Conflicts

6. Trichomonas Rapid Testing Market Landscape

• 6.1. Trichomonas Rapid Testing Market Share Analysis, 2024
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Trichomonas Rapid Testing Market - By Test Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
  • 7.1.2. Molecular Rapid Tests
  • 7.1.3. Immunochromatographic Tests
  • 7.1.4. Enzyme Immunoassays

8. Trichomonas Rapid Testing Market - By Sample Type

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Sample Type, 2024 & 2032 (%)
  • 8.1.2. Vaginal/Urethral Swabs
  • 8.1.3. Urine Samples

9. Trichomonas Rapid Testing Market - By End-user

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
  • 9.1.2. Hospitals
  • 9.1.3. Diagnostic Laboratories
  • 9.1.4. Clinics and Physician Offices
  • 9.1.5. Point-of-Care Testing Centers

10. Trichomonas Rapid Testing Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Trichomonas Rapid Testing Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Trichomonas Rapid Testing Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.8. UK
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.8.3. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.8.4. UK Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.3.8.5. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.9. France
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.9.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.9.4. France Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.3.9.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.10. Italy
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.10.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.10.4. Italy Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.3.10.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.11. Spain
    • 10.3.11.1. Overview
    • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.11.3. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.11.4. Spain Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.3.11.5. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.12. The Netherlands
    • 10.3.12.1. Overview
    • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.12.3. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.12.4. The Netherlands Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.3.12.5. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Overview
    • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.3.13.5. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.14. Russia
    • 10.3.14.1. Overview
    • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.14.3. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.14.4. Russia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.3.14.5. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.15. Poland
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.15.3. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.15.4. Poland Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.3.15.5. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.16. Rest of Europe
    • 10.3.16.1. Overview
    • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Trichomonas Rapid Testing Key Manufacturers in Asia Pacific
  • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.4.4. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  • 10.4.5. APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  • 10.4.6. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.7. China
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.7.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.7.4. China Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.4.7.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.8. India
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.8.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.8.4. India Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.4.8.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.12. Indonesia
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.12.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.12.4. Indonesia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.4.12.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.13. Thailand
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.13.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.13.4. Thailand Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.4.13.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
• 10.5. Latin America (LATAM)
  • 10.5.1. Overview
  • 10.5.2. Trichomonas Rapid Testing Key Manufacturers in Latin America
  • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.5.4. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  • 10.5.5. LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  • 10.5.6. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
• 10.6. Middle East and Africa (MEA)
  • 10.6.1. Overview
  • 10.6.2. Trichomonas Rapid Testing Key Manufacturers in Middle East and Africa
  • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.6.4. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  • 10.6.5. MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  • 10.6.6. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6.8. UAE
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.8.3. UAE Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.8.4. UAE Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.6.8.5. UAE Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Trichomonas Rapid Testing Industry

• 11.1. Competitive Dashboard
  • 11.1.1. Competitive Benchmarking
  • 11.1.2. Competitive Positioning
• 11.2. Company Profiles
  • 11.2.1. Quidel Corporation
  • 11.2.2. Hologic, Inc.
  • 11.2.3. Sekisui Diagnostics
  • 11.2.4. Abbott Laboratories
  • 11.2.5. Becton Dickinson and Company
  • 11.2.6. Thermo Fisher Scientific
  • 11.2.7. Bio-Rad Laboratories
  • 11.2.8. Meridian Bioscience, Inc.
  • 11.2.9. Siemens Healthineers
  • 11.2.10. Roche Diagnostics
  • 11.2.11. Alere Inc. (now part of Abbott)
  • 11.2.12. Cepheid
  • 11.2.13. F. Hoffmann-La Roche Ltd
  • 11.2.14. Luminex Corporation
  • 11.2.15. BioMerieux SA
  • 11.2.16. Ortho Clinical Diagnostics
  • 11.2.17. Mobidiag Oy
  • 11.2.18. GenProbe, Inc.
  • 11.2.19. Diasorin S.p.A
  • 11.2.20. Nanosphere, Inc.

12. 360 Degree AnalystView

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us